vs
NexPoint Real Estate Finance, Inc.（NREF）与礼来（RNA）财务数据对比。点击上方公司名可切换其他公司
礼来的季度营收约是NexPoint Real Estate Finance, Inc.的1.1倍（$12.5M vs $11.1M），NexPoint Real Estate Finance, Inc.净利率更高（216.6% vs -1398.3%，领先1615.0%），礼来同比增速更快（434.0% vs -48.8%）
NexPoint Real Estate Finance, Inc.是一家总部位于美国的商业地产金融企业，主要为多户住宅、写字楼、工业及酒店物业提供结构化融资方案，运营并管理抵押贷款及其他地产相关投资组合，为利益相关方提供经风险调整的稳定回报。
礼来是总部位于美国印第安纳州印第安纳波利斯的跨国制药企业，在18个国家设有办事处，产品销往全球约125个国家。公司由美国内战时期联邦军退伍军人、药剂师伊莱·礼来于1876年创立，品牌名即取自创始人姓名。
NREF vs RNA — 直观对比
营收规模更大
RNA
是对方的1.1倍
$11.1M
营收增速更快
RNA
高出482.9%
-48.8%
净利率更高
NREF
高出1615.0%
-1398.3%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $11.1M | $12.5M |
| 净利润 | $24.0M | $-174.4M |
| 毛利率 | — | — |
| 营业利润率 | — | -1513.5% |
| 净利率 | 216.6% | -1398.3% |
| 营收同比 | -48.8% | 434.0% |
| 净利润同比 | 58.7% | -117.0% |
| 每股收益（稀释后） | $0.47 | $-1.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NREFRNA
| Q4 25 | $11.1M | — | ||
| Q3 25 | $12.5M | $12.5M | ||
| Q2 25 | $12.1M | $3.8M | ||
| Q1 25 | $11.5M | $1.6M | ||
| Q4 24 | $21.7M | $3.0M | ||
| Q3 24 | $12.5M | $2.3M | ||
| Q2 24 | $6.7M | $2.0M | ||
| Q1 24 | $-12.8M | $3.5M |
净利润NREFRNA
| Q4 25 | $24.0M | — | ||
| Q3 25 | $50.9M | $-174.4M | ||
| Q2 25 | $22.3M | $-157.3M | ||
| Q1 25 | $26.0M | $-115.8M | ||
| Q4 24 | $15.2M | $-102.3M | ||
| Q3 24 | $23.3M | $-80.4M | ||
| Q2 24 | $12.1M | $-70.8M | ||
| Q1 24 | $-14.6M | $-68.9M |
营业利润率NREFRNA
| Q4 25 | — | — | ||
| Q3 25 | — | -1513.5% | ||
| Q2 25 | — | -4448.7% | ||
| Q1 25 | — | -8360.9% | ||
| Q4 24 | — | -4069.6% | ||
| Q3 24 | — | -4200.9% | ||
| Q2 24 | — | -4040.4% | ||
| Q1 24 | — | -2178.6% |
净利率NREFRNA
| Q4 25 | 216.6% | — | ||
| Q3 25 | 407.0% | -1398.3% | ||
| Q2 25 | 184.5% | -4089.3% | ||
| Q1 25 | 225.6% | -7360.0% | ||
| Q4 24 | 69.9% | -3439.5% | ||
| Q3 24 | 186.4% | -3441.7% | ||
| Q2 24 | 179.7% | -3461.8% | ||
| Q1 24 | 114.3% | -1943.4% |
每股收益（稀释后）NREFRNA
| Q4 25 | $0.47 | — | ||
| Q3 25 | $1.14 | $-1.27 | ||
| Q2 25 | $0.54 | $-1.21 | ||
| Q1 25 | $0.70 | $-0.90 | ||
| Q4 24 | $0.71 | $-0.80 | ||
| Q3 24 | $0.74 | $-0.65 | ||
| Q2 24 | $0.40 | $-0.65 | ||
| Q1 24 | $-0.83 | $-0.79 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $31.1M | $350.2M |
| 总债务越低越好 | $771.2M | — |
| 股东权益账面价值 | $388.0M | $1.9B |
| 总资产 | $5.3B | $2.1B |
| 负债/权益比越低杠杆越低 | 1.99× | — |
8季度趋势，按日历期对齐
现金及短期投资NREFRNA
| Q4 25 | $31.1M | — | ||
| Q3 25 | $17.9M | $350.2M | ||
| Q2 25 | $9.1M | $243.9M | ||
| Q1 25 | $19.2M | $254.2M | ||
| Q4 24 | $3.9M | $219.9M | ||
| Q3 24 | $34.7M | $370.2M | ||
| Q2 24 | $4.3M | $575.8M | ||
| Q1 24 | $13.5M | $471.4M |
总债务NREFRNA
| Q4 25 | $771.2M | — | ||
| Q3 25 | $720.9M | — | ||
| Q2 25 | $815.6M | — | ||
| Q1 25 | $831.5M | — | ||
| Q4 24 | $799.3M | — | ||
| Q3 24 | $815.5M | — | ||
| Q2 24 | $861.0M | — | ||
| Q1 24 | $843.3M | — |
股东权益NREFRNA
| Q4 25 | $388.0M | — | ||
| Q3 25 | $375.4M | $1.9B | ||
| Q2 25 | $348.2M | $1.2B | ||
| Q1 25 | $343.7M | $1.3B | ||
| Q4 24 | $336.5M | $1.4B | ||
| Q3 24 | $335.8M | $1.5B | ||
| Q2 24 | $327.5M | $1.2B | ||
| Q1 24 | $327.1M | $830.9M |
总资产NREFRNA
| Q4 25 | $5.3B | — | ||
| Q3 25 | $5.3B | $2.1B | ||
| Q2 25 | $5.4B | $1.4B | ||
| Q1 25 | $5.4B | $1.5B | ||
| Q4 24 | $5.4B | $1.6B | ||
| Q3 24 | $5.7B | $1.6B | ||
| Q2 24 | $6.6B | $1.3B | ||
| Q1 24 | $7.1B | $951.5M |
负债/权益比NREFRNA
| Q4 25 | 1.99× | — | ||
| Q3 25 | 1.92× | — | ||
| Q2 25 | 2.34× | — | ||
| Q1 25 | 2.42× | — | ||
| Q4 24 | 2.38× | — | ||
| Q3 24 | 2.43× | — | ||
| Q2 24 | 2.63× | — | ||
| Q1 24 | 2.58× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-4.5M | $-156.2M |
| 自由现金流经营现金流 - 资本支出 | — | $-156.9M |
| 自由现金流率自由现金流/营收 | — | -1257.6% |
| 资本支出强度资本支出/营收 | — | 5.7% |
| 现金转化率经营现金流/净利润 | -0.19× | — |
| 过去12个月自由现金流最近4个季度 | — | $-592.3M |
8季度趋势，按日历期对齐
经营现金流NREFRNA
| Q4 25 | $-4.5M | — | ||
| Q3 25 | $8.1M | $-156.2M | ||
| Q2 25 | $3.3M | $-199.7M | ||
| Q1 25 | $16.0M | $-124.8M | ||
| Q4 24 | $4.4M | $-99.9M | ||
| Q3 24 | $14.7M | $-65.6M | ||
| Q2 24 | $-7.5M | $-65.0M | ||
| Q1 24 | $17.7M | $-70.4M |
自由现金流NREFRNA
| Q4 25 | — | — | ||
| Q3 25 | — | $-156.9M | ||
| Q2 25 | — | $-203.0M | ||
| Q1 25 | — | $-128.6M | ||
| Q4 24 | — | $-103.8M | ||
| Q3 24 | — | $-67.3M | ||
| Q2 24 | — | $-65.5M | ||
| Q1 24 | — | $-71.3M |
自由现金流率NREFRNA
| Q4 25 | — | — | ||
| Q3 25 | — | -1257.6% | ||
| Q2 25 | — | -5277.1% | ||
| Q1 25 | — | -8174.3% | ||
| Q4 24 | — | -3491.0% | ||
| Q3 24 | — | -2881.8% | ||
| Q2 24 | — | -3204.6% | ||
| Q1 24 | — | -2012.3% |
资本支出强度NREFRNA
| Q4 25 | — | — | ||
| Q3 25 | — | 5.7% | ||
| Q2 25 | — | 86.9% | ||
| Q1 25 | — | 238.6% | ||
| Q4 24 | — | 131.7% | ||
| Q3 24 | — | 72.9% | ||
| Q2 24 | — | 26.0% | ||
| Q1 24 | — | 25.8% |
现金转化率NREFRNA
| Q4 25 | -0.19× | — | ||
| Q3 25 | 0.16× | — | ||
| Q2 25 | 0.15× | — | ||
| Q1 25 | 0.62× | — | ||
| Q4 24 | 0.29× | — | ||
| Q3 24 | 0.63× | — | ||
| Q2 24 | -0.62× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
